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In a previous communication (1) a simple medium for the cultivation 
of vaccine virus was described.  The results of the work reported at 
that time clearly indicate  that vaccine virus is capable of multiplica- 
tion in the presence of minced chick embryo tissue suspended in Ty- 
rode's  solution.  The  experiments,  however,  were  conducted  with  a 
neurovaccine virus, and, although the active agent engendered in cul- 
tures  caused  typical vaccinal lesions  in  rabbits,  it was deemed  best 
not to test it in human beings.  To obtain a culture virus for Jennerian 
prophylaxis in man, it seemed advisable to adapt a  dermal  strain of 
vaccine virus to our method  of cultivation.  The present paper deals 
with the results of this work. 
Method8 and Materials 
Virus.--Vaccine virus, Lot 611,  prepared  by the  New York  City  Board of 
Health was used to initiate the cultures.  In a letter to me, the original source of 
the virus is described by Mr. Chas. R. Tyler. 
"Regarding the history of our strain of vaccine virus:  the following statement appears 
in the Yearly Report of the New York City Board of Health for 1874-75. 
'We began vaccinating with virus of the same stock as that which had been supplied 
by the late Dr. Loines of the Eastern Dispensary and myself for about 5 years and which 
had been used and sold by him for about 20 years previously.  This virus was originally 
obtained from England by Dr. Loines and in all probability was descended from the stock 
furnished by Jenner.  As it always developed characteristic Jennerian vesicles and as it 
always thoroughly protected from smallpox those upon whom  it was used, Dr. Loines  never 
thought favorably of employing  any other.' 
"The same strain of virus has been in use since the time of this report.  The virus has 
been 'humanized' at various times, usually from one to three times yearly." 
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Tissues.--Embryonic  tissue was obtained from eggs, incubated 9  to  12  days, 
that had been opened according to the method of Carrel and Rivers (2) or that 
of Eagles and McClean (3).  If the embryos were contaminated by yolk, they were 
thoroughly washed in  sterile Tyrode's solution before being minced.  Further- 
more, the eyes were removed, because the pigment granules contained in them often 
led to confusion when smears were made to determine the sterility of the cultures. 
Finally, the embryos were placed in a sterile watchglass contained in a Petri dish, 
finely minced with  scissors, and  then  distributed in proper amounts  into flasks 
by means of a pipette. 
Tyrode's  Solution.--Tyrode's  solution  prepared  according  to  the  following 
formula and sterilized by filtration was used:  NaCl, 8 gin.; KC1, 0.2 gin.; CaCI~, 
0.2 gin.; MgCI~, 0.1 gm.; NaH2PO4, 0.05  gm.; NaHCO3, 1.0 gm.; glucose, 1.0 gin.; 
water q.s. 1000  cc.  During  the preparation and filtration of the solution,  CO~ 
is liberated, and the pH is found to be between 8.0 and 8.4.  When living tissue 
is added to the solution, however, CO~ is supplied by it and the pH becomes less 
alkaline reaching a point compatible with the survival of the embryonic tissue and 
the multiplication of the virus. 
Containers.--Containers  for the production of vaccine virus in large amounts 
must be of sufficient size and easy to handle.  Furthermore,  they must permit 
aeration  and  prevent  contaminations  and  evaporation.  Flasks  (collar  flasks) 
designed to meet these requirements were described in a  previous paper (1)  and 
have been found to be satisfactory for this work.  Two sizes have been used, one 
with approximately the dimensions of a  50  cc. Erlenmeyer  flask, the other with 
approximately the volume of a  250 cc. Erlenmeyer flask.  In the small container 
5 cc. of medium were placed, while in the large one 15 cc. were used.  Such small 
amounts were placed in each flask in order to have the medium distributed as a 
thin layer.  In case collar flasks  cannot  be  obtained, 50 cc. and 250  cc. Erlen- 
meyer flasks  make  good  substitutes.  All glassware used in  this type of work 
should be made of an alkali-free resistant glass, e.g., pyrex. 
Preparation  of Cultures.--Approximately  1 gin. of minced chick embryo tissue 
to each 5 cc. of Tyrode's solution was used.  Proper amounts of  tissue suspended 
in its vehicle were distributed in flasks.  The medium was then inoculated with 
0.25 cc. of virus emulsion, the mouth of each flask containing its cotton plug was 
securely covered with several layers of tin-foil, and the cultures were incubated 
at 37°C. for 5 days.  New  cultures were made by direct transfer of 0.25 cc. of an 
old culture into flasks of fresh medium.  In this simple manner,  vaccine virus 
can be propagated through  an  indefinite number  of culture  generations.  One 
should be careful not to use too much tissue for a given amount of Tyrode's solu- 
tion, inasmuch as it appears that an optimum ratio between tissue and fluid exists 
for the ma~dmal multiplication of virus. 
Tests for Sterility  of the Cultures.--Early in the work, the medium was tested 
for sterility before it was inoculated with virus.  During the interval (48 hours), 
the  prepared flasks were  stored at  -{-5°C.  Later  these preliminary tests were 
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transfer  in order to escape the possibility of having the work delayed by bacterial 
contaminations.  After  the  cultures  had  been  incubated  for  3  days,  a  small 
amount of material was removed from each one and seeded in broth tubes and on 
blood agar plates.  After the virus cultures had been incubated for 5 days, smears 
from each one were prepared, stained,  and examined for bacteria.  The material 
in the flasks that was found by cultural tests and smears to be free from bacteria 
was  used  for  transfers  and  animal  inoculations.  Numerous flasks  have  been 
handled in  the manner described  above and only 1 in 12 became contaminated 
with bacteria. 
Tests for Potency of Virus.--Cultures for titration were ground in sterile  mor- 
tars,  and then appropriate dilutions  were made with Locke's solution.  A fresh 
pipette was always used  for each  successive  dilution.  0.25 ec. of each dilution 
were injected  into the shaved skin or were smeared  on the scarified shaved skin 
of rabbits.  In addition  to rabbits,  monkeys and  human  volunteers  were  em- 
ployed for the potency tests of the virus. 
Preservation of the  Virus.--Many  workers  have  stated  that  culture  virus is 
difficult to preserve.  This is true of viruses cultivated in certain kinds of media. 
It must be borne in mind, however, that no vaccine virus keeps indefinitely above 
O°C..Furthermore, when glycerol is used, care must be exercised in selecting one 
that  will not  inactivate  the  virus.  Merck's  (P-W-R  Analytical  Chemicals) 
glycerol has been found suitable  for this work. 
EXPERIMENTAL 
The  vaccine  virus  distributed  by  the  New  York  City  Board  of' 
Health is  prepared  on calves,  ripened in  glycerol  at  about  -8°C., 
and  then  treated  with  brilliant  green.  The bacterial  count in  such 
material is low.  Indeed, at  times,  the virus seems to be entire]~y free 
from viable microorganisms.  A  specimen from Lot 611 was obtained 
from  the  Board  of Health  Laboratories,  and  with  it  cultures  were 
initiated.  At first it appeared that we had been fortunate enough to 
obtain a  virus free from bacteria,  but soon it was discovered that a 
very slow-growing diptheroid was  present  as  a  contaminant.  Con- 
sequently we were faced with the problem of how to rid the virus cul- 
tures  of the bacteria.  Filtration  was first  considered as  a  means of 
accomplishing this,  but it  was not attempted  because vaccine virus 
filters with difficulty.  Then we decided to try passage through rab- 
bits in the following manner. 
Rabbit 1 received in each testicle 1 cc. of a culture containing diphtheroids  and 
vaccine virus.  4 days later the testicles were removed and emulsified with Locke's 
solution.  1 cc. of the emulsion was injected into each testicle of Rabbit 2.  After 456  VACCINE  VIRUS  FOR  PROPR'MLAXIS 
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virus  was adapted to a culture  medium consisting  of minced chick  embryo sus- 
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a lapse  of 4 days, blood (4) was removed  1 aseptically from the heart of Rabbit 
2 and immediately injected in 1 cc. amounts into the testicles of Rabbit 3.  This 
animal developed fever on the 4th day, and small hard nodules were felt in the 
testicles.  At this time the testicles were removed and emulsified with Locke's 
solution.  1 cc. of the emulsion was inoculated in each testicle of Rabbit 4.  After 
4 days these testicles were removed and ground in a mortar without sand.  Ap- 
proximately 20 cc. of Tyrode's solution were thoroughly mixed with the macerated 
tissue.  The emulsion  was tested for the presence of bacteria and was found to 
be sterile.  Then small  amounts  (0.25 cc.)  of the supernatant material from a 
centrifuged specimen of the emulsionwere used to initiate a series of virus cultures 
(see Text-fig. 1). 
Having rid the dermal vaccine virus of bacteria it remained for us 
to  determine whether it was  possible  to  adapt  such  a  strain  to our 
method of cultivation.  Proceeding in  the  manner described above, 
we have been able to carry the virus through an uninterrupted series 
of 15 culture generations  (Text-fig. 1), and there is no reason to sup- 
pose  that  it  cannot  be  cultivated  indefinitely.  The  records  6f  the 
titrations of the virus shown in Text-fig. 1 leave no room for doubt 
concerning the multiplication of the active agent.  Fu~hennore, fresh 
cultures have been initiated  with  glycerolated material  (Text-fig.  1) 
stored for 30 days at  +2.5°C.  Such facts make it evident that vac- 
cine virus is capable of indefinite propagation in cultures without the 
intervention of animal passage. 
Reactions  in Animals 
It has been shown that a  dermal strain of vaccine virus is capable 
of  multiplication  in  a  medium  consisting  of  minced  chick  embryo 
suspended  in  Tyrode's  solution.  The  question  as  to  whether  the 
virus has been altered by such treatment naturally arises.  To inves- 
tigate this matter, rabbits and monkeys were employed. 
Material from each set of cultures, with the exception of the 1st, has been tested 
by intradermal inoculations in the shaved skin of rabbits.  The reactions caused by 
the virus have not been altered through the process of cultivation, and have always 
been similar  to those produced by a potent strain of vaccine virus unassociated 
with bacteria.  This fact is illustrated by Fig.  1 that portrays lesions following 
intradermal injections of different dilutions of a  culture in the 14th generation. 
In addition to intradermal injections,  inoculations on the scarified shaved skin of 
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rabbits have been made from time to time.  Following  such inoculations, typical 
vaccinal lesions  unassociated with hemorrhage and  necrosis  developed.  Fig.  2 
represents lesions produced by different dilutions of a culture in the 6th generation. 
Finally, it has been shown that the culture virus smeared on the scarified  skin of 
monkeys  (Macacus rhesus) induces  typical  vaccinal  lesions  that  heal  rapidly 
without resultant injury to the animals. 
From  the  above  experiments  it  is  obvious  that  the  culture  virus 
caused  typical vaccinal  lesions  in  animals.  We  then  became inter- 
ested  in  determining  whether  the  active  agent  had  undergone  im- 
munological  changes.  Consequently  the  followilag  cross  immunity 
experiments were performed. 
Rabbits inoculated respectively with virus from the 6th,  8th,  10th,  and 11th 
culture generations were allowed  to recover.  Then,  they and  2  normal stock 
rabbits were inoculated with New York City Board of Health vaccine virus, Lot 
617.  The recovered animals were refractory while  the  normal ones developed 
typical vaccinal lesions. 
The  above  experiment  indicates  that  repeated  cultivation  of  the 
virus in  a  medium  consisting  of minced  chick  embryo suspended  in 
Tyrode's solution  did not alter its antigenic properties. 
Reactions in Human  Volunteers 
Not infrequently we receive requests for vaccination against small- 
pox.  Since there was no valid reason for not using the culture  virus 
in human  beings,  we decided,  with  the consent of the patients or of 
their  parents,  to  substitute  in  certain  instances  the  culture  vaccine 
for calf lymph.  The results obtained in 3 children are detailed below. 
J. w., aged 2 years, May 2, was vaccinated at 2 points on the outer surface of 
the upper left arm.  The superior inoculation was made with material from a 5th- 
generation culture  that had been preserved in 50 per cent glycerol at  +2.5°C. 
for 28 days.  The inferior inoculation was made with material from a 10th-genera- 
tion culture that had been preserved in 50 per cent glycerol at +2.5°C. for 2 days. 
The method of vaccination consisted of a small amount of the virus being smeared 
over an area of skin previously superficially scarified.  May 3, superficial marks at 
points of inoculation.  May 4, no change.  May 5, 9:00 a.m., both lesions,  the 
lower slightly more than  the  upper,  show  some swelling  and  elevation.  2:30 
p.m., there have appeared, particularly over the area of the lower inoculation, 
crops of small vesicles  (Fig. 3).  No fever.  May 6, lesions well developed.  Both 
are small, the upper being about 0.5 cm. in diameter, the lower about 1.0 cm. (Fig. T.  ~r.  ~IwRs  459 
4).  Temperature rose to 101.2°F.  May 7, lesions have increased in diameter (Fig. 
5).  Temperature rose to 101.6°F.  May 8, lesions are still increasing in size and 
are now pustular (Fig. 6).  Temperature rose to 102°F.  Further development of 
the lesions not observed, because the child had to leave town with its parents. 
L. G., aged 22 months, May 11, was vaccinated at one point on the outer sur- 
face of upper left arm with material from an 1  lth-generation culture that had been 
preserved in 50 per cent glycerol at -k2.5°C. for 11 days.  May 12, no evidence of 
inflammation.  May 13, vaccinated area red but  not  elevated  (Fig.  11).  May 
14, at point of inoculation, there is a red papule (Fig.  12).  May 15, several small 
vesicles  have appeared (Fig.  13).  May 16, vesicles  have coalesced  and are  be- 
ginning to be pustular.  Narrow primary areola is present  (Fig.  14).  May 17, 
lesion somewhat larger, no induration, no fever.  May 18, lesion has increased in 
size and is beginning to dry in center (Fig.  15); no fever.  May 19, pustule larger 
(Fig.  16), no  induration,  no fever.  May  20,  pustule  larger,  drying;  secondary 
areola 3 turn. in width; slight amount of induration (Fig.  17).  Temperature rose 
to 100.4°F.  May 21, pustule drying, secondary areola 4 mm. in width, indura- 
tion more marked (Fig.  18).  Temperature 100.0°F.  May 22, secondary areola 
1 an. in diameter, induration more marked (Fig. 19); no fever.  Patient was rein- 
oculated on right arm with New York City Board of Health vaccine virus, Lot 
617.  May 23,  primary vaccination: secondary areola has almost disappeared, 
induration less (Fig. 20).  Secondary vaccination:  skin  at point  of inoculation 
red.  No  fever.  May  25,  primary  vaccination: lesion  covered  by  dry  scab; 
secondary areola and induration no longer present (Fig. 21).  Secondary vaccina- 
tion:  slightly  red.  May  26,  primary  vaccination: only  a  dry  scab  remains. 
Secondary vaccination: negative.  May 28, primary vaccination:  the  scab will 
drop off in a few days (Fig.  22).  Secondary vaccination: negative.  Patient in 
excellent condition and discharged from the hospital.  The virus with which this 
patient was reinoculated was shown to be potent by a successful vaccination of a 
normal person.  Thus, the lack of response to the secondary inoculation indicates 
that a state of immunity had been induced by the primary vaccination. 
After  it  had  been  demonstrated  that  the  culture  virus  produces 
without  danger a  typical vaccinia in man and that it induces an im- 
munity against  calf lymph, we decided,  in  view of the  fact that  the 
culture  vaccine  seemed  to  possess  a  greater  potency  than  does  or- 
dinary  calf lymph,  to  compare the  action of the  two kinds of active 
agent. 
M. S., aged 11 months, and J. S., aged 22 months, were vaccinated; the former 
with New York City Board of Health virus, Lot 617, that had been stored in 50 
per cent glycerol below 0°C. for more than a year, the latter with virus from an 
11th-generation culture that had been preserved in 50 per cent glycerol at -[-2.5°C. 
for 21  days.  Typical vaccinia developed in  both children who showed no evi- 460  VACCINE VIRUS FOR  PROPHYLAXIS 
dences of illness except a  local reaction  and  a  slight elevation of temperature, 
101.5°F.  Certain differences, however, were noted in the course of the infection 
in the 2 patients,  v/z., the child who was inoculated with the culture virus had a 
more prolonged febrile reaction and developed more redness and induration asso- 
ciated with a few secondary vesicles around  the  vaccinal pustule  than  did  the 
infant who received the calf lymph (Figs. 7 to 10). 
The experiment just described and others that will not be presented 
at this time indicate that  the culture virus is very potent.  The fact 
that  fresh culture vaccine produces considerable reaction is not sur- 
prising,  inasmuch  as it has long been known that  a "green" virus is 
more likely to give rise to redness, induration,  and secondary vesicles 
than  is  one  properly  aged.  Therefore,  the  culture  virus  should  be 
allowed to ripen before it is used for vaccination of human beings. 
DISCUSSION 
The medium employed for the in vitro cultivation of vaccine virus is 
exceedingly  simple,  but one must  remember  that  it  contains  living 
cells.  In  spite  of  recent  reports  (5)  to  the  contrary,  no  one  has 
definitely shown (6, 7) that vaccine virus is capable of pullulation in 
the absence of surviving susceptible cells. 
Several  kinds  of media  have  been  devised for  the production  of 
vaccine virus.  The one described in this paper, however, is the best 
of the lot already proposed, because, inasmuch  as  neither serum nor 
plasma is used and since the tissue consists of minced chick embryo, 
it is the least likely to become contaminated  by an exfraneous virus 
injurious  to man.  Furthermore,  the virus produced in this manner 
remains potent in 50 per cent glycerol at +2.5°C. for at least a month. 
More information,  however,  concerning  the length  of time  the  cul- 
ture vaccine remains  active under  a  variety of conditions  should be 
obtained and to this end experiments are now being conducted. 
SUMMARY 
1.  A  dermal strain  of vaccine virus has been adapted  to  a  simple 
culture  medium  consisting  of  minced  chick  embryo  suspended  in 
Tyrode's solution. 
2.  The bacteria-free culture virus, thus obtained, produces in lower 
animals and in man typical vaccinia  that renders  them refractory to 
infection with ordinary vaccine virus  harvested from cMves. T.  M.  RIVERS  461 
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EXPLANATION OF  PLATES 
PLATE 45 
FIe.  1.  Lesions  produced  in  a  rabbit  by intradermal  inoculations  (0.25  cc.) 
of 10 -3,  10 -3,  10 -4,  10 -5, and  10 -6  dilutions,  respectively, of a  14th-generation 
culture of vaccine virus.  ×  1. 
FIG.  2.  Lesions  induced  in  a  rabbit  by  different  dilutions  (undiluted,  10 -1, 
10 -3, l0 -8, 10 -4) of a 6th-generation culture of vaccine virus.  ×  1. 
PLATE 46 
FIGS. 3  to 6.  3rd-,  4th-, 5th-, and 6th-day vaccinal lesions, respectively, pro- 
duced in J. W. by culture virus:  the upper resulted from an inoculation of a 5th- 
generation  culture,  the  lower from an  infection with  a  10th-generation  culture. 
×1. 
FIGS. 7, 9.  6th- and 9th-day vaccinal lesions, respectively, produced in M. S. 
by New York City Board of Health virus, Lot 617.  Compare with Figs. 8 and 
10.  ×  1. 
FIos. 8,  10.  6th- and 9th-day vaccinal lesions,  respectively,  induced in J.  S. 
by  an  llth-generation  culture.  Comparison  of  these  reactions  with  those  in 
Figs.  7 and 9  shows that the culture vaccine, only 21  days old, caused more red- 
ness and secondary vesicles than did the City Board of Health virus that had been 
aged for more than a year.  ×  1. 
PLATE 47 
FIGS.  ll  to  22.  2nd-,  3rd-,  4th-,  5th-,  7th-,  8th-,  9th-,  10th-,  llth-,  12th-, 
13th-,  and  18th-day vaccinal lesions, respectively, produced in L.  G. by a  10th- 
generation  culture.  The photographs portray the complete evolution of a  vac- 
cinal'lesion induced in man by a dermal strain of virus adapted to in v/tro cultiva- 
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